Can a nasal spray treat anaphylaxis? Find out about this and more in today's PeerDirect Medical News Podcast.

In part two of this discussion, Corinne Young, MSN, FNP‑C, FCCP, and Jessica Glennie, CNP, talk about the role of advanced practice providers in rural areas and how their role may differ from larger medical centers.

Corinne Young, MSN, FNP‑C, FCCP, and Jessica Glennie, CNP, share insights on identifying, diagnosing, treating, and setting goals of care for patients with ILDs as advanced practice providers in a variety of practice settings (Part 1 of 2).

Drs. Callahan and Yuan share their insights into HER2‑low breast cancer, including the evolving definitions and testing approaches, and exploring how these results can impact treatment.

Join Drs. Yuan and Callahan as they continue their discussion on HER2+ testing by reviewing our current understanding of HER2+ low and how it differs from HER2+ and HER2 negative. They explore the role of neoadjuvant therapy in HER2+ patients, post-operative phenotype shifts, and the need for HER2+ testing after surgery. They share cases from their practices where these issues arose and discuss how clinicians should approach post-treatment testing, including the concept of microtumor residual disease. Additionally, they examine precision medicine's role in improved HER2+ testing, including the potential of AI to enhance testing accuracy. Finally, they discuss the distinctions between HER2 low and HER2 ultralow.

Which modifiable factors can cut risk of dementia in half? Find out about this and more in today's PeerDirect Medical News Podcast.

Drs. Yuan and Callahan discuss HER2 testing in breast cancer. They will explore the clinical relevance and need for testing, and discuss testing methods, evolving testing guidelines, and interpretation of results.

Can a twice-yearly shot provide 100% protection against HIV? Find out about this and more in today's PeerDirect Medical News Podcast.

Drs. Vela and Adegunsoye explore the intersections of patient education, community engagement, and healthcare policies, particularly in addressing the needs of underrepresented racial groups. Monica emphasizes the value of long-term patient-physician relationships in primary care, the necessity of interrupting physician biases, and the importance of systemic changes to facilitate more comprehensive patient interactions. Deji highlights the need for community-based outreach and clinical trial participation to address health disparities, particularly in Black communities. Both underscore the importance of innovative communication strategies to build trust and educate communities about diseases affecting them disproportionately. Their conversation envisions a brighter future with more effective and inclusive healthcare practices.

Drs. Vela and Adegunsoye delve into the racial disparities in the diagnosis and progression of pulmonary fibrosis, particularly within the black population. They discuss the role of environmental and occupational exposures, and the impact of cultural and autoimmune factors on the disease's prevalence in black communities. Dr. Adegunsoye emphasizes that black individuals are at a higher risk for autoimmune disorders, which can lead to pulmonary fibrosis. Moreover, he highlights the flaws in lung function tests that use race adjustments, often masking the real health conditions in black patients. The discussion also addresses the critical issue of delayed diagnosis, which adversely affects the prognosis of pulmonary fibrosis. Both presenters stress the importance of early screening, equitable access to care, and policy changes to improve outcomes for marginalized populations. They conclude by noting the need for action plans to address these disparities, pointing out that black individuals often get diagnosed and die from pulmonary fibrosis at an earlier age compared to other racial groups.